Golden State Equity Partners’s Genocea Biosciences, Inc. GNCA Stock Holding History

Golden State Equity Partners’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,958	Closed	–	–	1897
2026 Q1	$0	Buy	+2,958	New	–	﹤0.01%	2045

Golden State Equity Partners's GNCA Position: Q2 2026 in Review

Golden State Equity Partners sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2026, closing a stake of 2,958 shares.

Golden State Equity Partners first reported a position in GNCA in Q1 2026 and held it in 1 quarter. The position peaked at $0 in Q1 2026. 0 funds tracked by Wall St. Rank hold GNCA as of Q2 2026.

Golden State Equity Partners reported no remaining Genocea Biosciences, Inc. position as of Q2 2026 after selling out during the quarter.
Golden State Equity Partners sold 2,958 Genocea Biosciences, Inc. shares in Q2 2026.
Golden State Equity Partners first reported a position in Genocea Biosciences, Inc. in Q1 2026 and held it in 1 quarter.
Golden State Equity Partners's Genocea Biosciences, Inc. position peaked at $0 in Q1 2026.
0 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.